Pablo Mallaroni

My key interest is demystifying psychedelia for clinical use. I am working on placebo-controlled clinical trials to assess acute effects of NPS (JWH-018, 3MMC, 4-FA, 2C-B ) and classical reference drugs (cannabis, MDMA, cocaine, psilocybin) on resting state networks, neurocognition and metabolomics The objective is to generate algorithms to predict the similarity of new psychoactives to classical drugs for risk classification and identification of novel therapeutics.